OneDigital Investment Advisors’s ProQR Therapeutics PRQR Stock Holding History

OneDigital Investment Advisors’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$138K	Hold	85,000	–	–	﹤0.01%	1416
2025 Q4	$172K	Buy	85,000 +5,000	+6%	+$11.7K	﹤0.01%	1456
2025 Q3	$170K	Buy	80,000 +15,000	+23%	+$32.8K	﹤0.01%	1440
2025 Q2	$133K	Buy	65,000 +25,000	+63%	+$40.7K	﹤0.01%	1404
2025 Q1	$53.2K	Buy	40,000 +12,500	+45%	+$26.6K	﹤0.01%	1375
2024 Q4	$72.9K	Sell	27,500 -30,050	-52%	-$95.4K	﹤0.01%	1371
2024 Q3	$105K	Buy	57,550 +15,550	+37%	+$29.2K	﹤0.01%	1399
2024 Q2	$69.7K	Sell	42,000 -3,000	-7%	-$5.83K	﹤0.01%	1334
2024 Q1	$103K	Buy	45,000 +13,050	+41%	+$27.9K	﹤0.01%	1056
2023 Q4	$63.3K	Buy	31,950 +12,425	+64%	+$19.1K	﹤0.01%	1084
2023 Q3	$25.4K	Buy	19,525 +4,225	+28%	+$6.65K	﹤0.01%	977
2023 Q2	$24.8K	Buy	+15,300	New	+$29.9K	﹤0.01%	1001

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

OneDigital Investment Advisors's PRQR Position: Q1 2026 in Review

OneDigital Investment Advisors held its ProQR Therapeutics (PRQR) position steady in Q1 2026 at 85,000 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

OneDigital Investment Advisors first reported a position in PRQR in Q2 2023 and has held it in 12 quarters since. The position peaked at $172K in Q4 2025. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

OneDigital Investment Advisors held 85,000 shares of ProQR Therapeutics worth $138K as of Q1 2026.
OneDigital Investment Advisors left its ProQR Therapeutics share count unchanged in Q1 2026.
ProQR Therapeutics made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q1 2026, its #1416 holding.
OneDigital Investment Advisors first reported a position in ProQR Therapeutics in Q2 2023 and has held it in 12 quarters since.
OneDigital Investment Advisors's ProQR Therapeutics position peaked at $172K in Q4 2025.
69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.